CONMED Corp — Director's Dealing 2023

Jun 9, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-06-01

Reporting Person: Ferrell John D. (Executive Vice President - HR)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	702	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options To Purchase Common Stock	$41.93	2027-03-01	Common Stock (1700)		Direct
Options To Purchase Common Stock	$59.96	2028-03-01	Common Stock (9000)		Direct
Options To Purchase Common Stock	$78.76	2029-03-01	Common Stock (9000)		Direct
Options To Purchase Common Stock	$97.69	2030-03-02	Common Stock (9000)		Direct
Options To Purchase Common Stock	$122.55	2031-03-01	Common Stock (9000)		Direct
Options To Purchase Common Stock	$144.55	2032-03-01	Common Stock (8500)		Direct
Options To Purchase Common Stock	$96.16	2033-03-01	Common Stock (12000)		Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period